Here are the Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.
Global prevalence of type 2 diabetes, global epidemiology of heart failure, global epidemiology of atrial fibrillation, global epidemiology of hypertension, type 2 diabetes global statistics, clinical epidemiology and global health, type 2 diabetes epidemic, prevalence of type 2 diabetes worldwide, global epidemiology of heart failure, type 2 diabetes statistics worldwide.
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis
Background: Non-alcoholic fatty liver disease (NAFLD) and metabolic-associated fatty liver disease (MAFLD) shares common pathophysiological mechanisms with type 2 diabetes, making them significant risk factors for type 2 diabetes. The present study aimed to assess the epidemiological feature of type 2 diabetes in patients with NAFLD or MAFLD at global levels.
Methods: Published studies were searched for terms that included type 2 diabetes, and NAFLD or MAFLD using PubMed, EMBASE, MEDLINE, and Web of Science databases from their inception to December 2022. The pooled global and regional prevalence and incidence density of type 2 diabetes in patients with NAFLD or MAFLD were evaluated using random-effects meta-analysis. Potential sources of heterogeneity were investigated using stratified meta-analysis and meta-regression.
Results: A total of 395 studies (6,878,568 participants with NAFLD; 1,172,637 partici pants with MAFLD) from 40 countries or areas were included in the meta-analysis. The pooled prevalence of type 2 diabetes among NAFLD or MAFLD patients was 28.3% (95% confidence interval 25.2–31.6%) and 26.2% (23.9–28.6%) globally. The incidence density of type 2 diabetes in NAFLD or MAFLD patients was 24.6 per 1000-person year (20.7 to 29.2) and 26.9 per 1000-person year (7.3 to 44.4), respectively. Conclusions: The present study describes the global prevalence and incidence of type 2 diabetes in patients with NAFLD or MAFLD. The study findings serve as a valuable resource to assess the global clinical and economic impact of type 2 diabetes in patients with NAFLD or MAFLD. © The Author(s) 2024.
Authors : Cao L.; An Y.; Liu H.; Jiang J.; Liu W.; Zhou Y.; Shi M.; Dai W.; Lv Y.; Zhao Y.; Lu Y.; Chen L.; Xia Y.
Source : BioMed Central Ltd
Article Information
| Year | 2024 |
| Type | Article |
| DOI | 10.1186/s12916-024-03315-0 |
| ISSN | 17417015 |
| Volume | 22 |
You can download the article here
If You have any problem, contact us here